Coventry University Featured PhD Programmes
Brunel University London Featured PhD Programmes
Newcastle University Featured PhD Programmes
John Innes Centre Featured PhD Programmes
University of Reading Featured PhD Programmes
"pancreatic" AND "cancer"…×
10 miles

pancreatic cancer PhD Projects, Programs & Scholarships

We have 11 pancreatic cancer PhD Projects, Programs & Scholarships

  • "pancreatic" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 11
  Development of a pancreatic cancer cell migration and invasion high content image analysis pipeline.
  Research Group: Randall Division of Cell and Molecular Biophysics
  Dr M Krause
Application Deadline: 9 April 2019
Pancreatic cancer is a very devastating disease with a very low survival rate due to the uncontrolled metastatic spread. The first step in metastasis is local invasion followed by intravasation into the blood stream.
  Biological significance, predictive value and targeting of the HER family members in pancreatic cancer
  Prof H Modjtahedi
Applications accepted all year round
Despite major advances in imaging technologies, surgery, chemotherapy, radiotherapy and targeted therapy of cancer in the last few decades, pancreatic cancer remains as one of the most aggressive and fatal types of human cancer.
  Targeting lipid metabolism in pancreatic cancer
  Dr M Stolinski
Applications accepted all year round
Pancreatic cancer is associated with poor prognosis and substantial rates of mortality. The need for new treatment options is therefore of utmost importance.
  Second generation nano-carriers for pancreatic cancer therapy
  Dr C Hoskins
Application Deadline: 18 May 2019
We are looking to recruit a PhD student with a relevant chemical, biomedical science or bioengineering background to design and develop novel nanomedicine platforms for chemotherapy.
  Influence of hybrid nanoparticle architecture on theranostic abilities in pancreatic cancer
  Dr C Hoskins
Application Deadline: 18 May 2019
We are looking to recruit a PhD student with a relevant chemical, biomedical science or bioengineering background to design and develop novel nanomedicine platforms for chemotherapy.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
  FGFR signalling in breast cancer
  Dr A Chioni
Applications accepted all year round
Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate.
  Multimerisation of ELAV/Hu proteins – a key mechanism ensuring specificity for RNA recognition in health and disease
  Dr M Soller, Dr T Knowles
Applications accepted all year round
Aims. Determine the structure of the ELAV dodecameric complex bound to target RNA by cryoEM and functionally probe interaction interfaces in vitro and in vivo in transgenic Drosophila models for neurodegeneration and cancer.
  The role of matrix interactions in regulating the SPARC family of matricellular proteins.
  Dr N Hill, Dr A Munasinghe
Applications accepted all year round
The SPARC family of matricellular proteins determine the way in which cells respond to their extracellular environment. SPARC family proteins interact with a range of binding partners, including matrix proteins (1).
  Investigating the Potential Benefits of MRI-LINAC for Delivery of Stereotactic Ablative Radiotherapy (SBRT) in Hepatobiliary Malignancies (Deadline extended)
  Dr M Hawkins, Prof F Van den Heuvel
Application Deadline: 30 April 2019
SBRT has been investigated as an alternative to conventionally fractionated radiotherapy for the local treatment of pancreatic cancer and liver malignancies.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.